DFX Intelligence
Data Factory
Reading the graph
Reading the graph
advised by REDMILE GROUP
Delaware, United States
Data as of (this record's last observation) from federal regulator filings. Page built and rebuilt at most every 15 minutes.
| Filed | GAV | Owners | Minimum | Adviser owns | Audited | Name as filed |
|---|---|---|---|---|---|---|
| Jul 3, 2024 | $1.2B | 330 | $5.0M | 500.0% | yes | REDMILE BIOPHARMA INVESTMENTS III, L.P. |
| Mar 28, 2024 | $1.2B | 330 | $5.0M | 500.0% | yes | REDMILE BIOPHARMA INVESTMENTS III, L.P. |
| May 5, 2023 | $1.1B | 329 | $5.0M | 500.0% | yes | REDMILE BIOPHARMA INVESTMENTS III, L.P. |
| Mar 31, 2023 | $1.1B | 329 | $5.0M | 500.0% | yes | REDMILE BIOPHARMA INVESTMENTS III, L.P. |
| Aug 15, 2022 | $1.1B | 342 | $5.0M | 500.0% | yes | REDMILE BIOPHARMA INVESTMENTS III, L.P. |
| May 6, 2022 | $1.1B | 342 | $5.0M | 500.0% | yes | REDMILE BIOPHARMA INVESTMENTS III, L.P. |
| Mar 31, 2022 | $1.1B | 342 | $5.0M | 500.0% | yes | REDMILE BIOPHARMA INVESTMENTS III, L.P. |
| Feb 9, 2022 | $554M | 117 | $5.0M | 400.0% | yes | REDMILE BIOPHARMA INVESTMENTS III, L.P. |
| Dec 2, 2021 | $554M | 117 | $5.0M | 400.0% | yes | REDMILE BIOPHARMA INVESTMENTS III, L.P. |
| Mar 31, 2021 | $554M | 117 | $5.0M | 400.0% | yes | REDMILE BIOPHARMA INVESTMENTS III, L.P. |
| Feb 26, 2021 | $554M | 116 | $5.0M | 400.0% | yes | REDMILE BIOPHARMA INVESTMENTS III, LP |
| Custodian | Legal name | City | State | Country | Related person | SEC number |
|---|---|---|---|---|---|---|
| JP MORGAN CHASE BANK | JP MORGAN CHASE BANK, N.A. | NEW YORK | New York | United States | no | n/a |
| MORGAN STANLEY & CO. LLC | MORGAN STANLEY & CO. LLC | SAN FRANCISCO | California | United States | no | 8-15869 |